Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 15.05
0.00 (0.00%)
Last updated: Oct 6, 2026, 5:26 PM CET
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €113.12 million as of October 6, 2026. Its market cap has increased by 159.22% in one year.
Market Cap
113.12M
Enterprise Value
110.92M
Revenue
9.69M
Ranking
n/a
PE Ratio
39.05
Stock Price
€15.05
ChartMarket Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 113.12M, an increase of 636.06%. That is a compound annual growth rate of 54.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 113.12M | 75.84% |
| Dec 31, 2025 | 64.33M | 294.97% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.72B |
| Laboratorios Farmaceuticos Rovi | 2.94B |
| Almirall | 2.23B |
| Faes Farma | 1.41B |
| Clínica Baviera | 891.44M |
| Oryzon Genomics | 223.92M |
| Laboratorio Reig Jofre | 215.04M |
| Prim, S.A. | 214.30M |